Inventor · disambiguated record
Martin Ritter
Also filed as: RITTER MARTIN
8 granted patents·13 pending applications·12 citations·filing 2017–2024
79Inventor score
Files withHOFFMANN LA ROCHE21
Top patents by PatentIndex Score
21 records- 0192US11802133B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Granted Oct 31, 2023·2 cites·10 claims
- 0292US11390610B2Piperazine derivatives as MAGL inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jul 19, 2022·6 cites·38 claims
- 0391US11981661B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2021·Granted May 14, 2024·2 cites·17 claims
- 0490US11814375B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Nov 14, 2023·2 cites·17 claims
- 0581US12281124B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2023·Granted Apr 22, 2025·0 cites·20 claims
- 0667US2024383904A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0766US2023117324A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0865US2020308190A1Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0964US2024199587A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1063US2022106328A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1162US2022267349A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1262US2023203056A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1361US2025099448A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1458US2021094972A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1558US2021107920A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1656US2021107921A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1754US2022202963A1Radiolabeled compoundsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1852US10435407B2Triaza-spirodecanones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Oct 8, 2019·0 cites·23 claims
- 1949US10239876B2Triaza-spirodecanones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2017·Granted Mar 26, 2019·0 cites·25 claims
- 2049US2021094973A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2142US10618897B2Spiroindolinones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Apr 14, 2020·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Martin Ritter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →